$INTC
Intel Corp

2020 Q3 Form 10-Q Financial Statement

#000005086320000043 Filed on October 23, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $18.33B $20.21B $19.19B
YoY Change -4.47% 8.32% 0.14%
Cost Of Revenue $8.592B $8.331B $7.895B
YoY Change 8.83% 12.13% 16.05%
Gross Profit $9.741B $11.88B $11.30B
YoY Change -13.76% 5.8% -8.62%
Gross Profit Margin 53.13% 58.78% 58.86%
Selling, General & Admin $1.435B $1.542B $1.536B
YoY Change -6.58% 1.45% -4.3%
% of Gross Profit 14.73% 12.98% 13.6%
Research & Development $3.272B $3.384B $3.208B
YoY Change 2.0% -1.43% -6.42%
% of Gross Profit 33.59% 28.49% 28.4%
Depreciation & Amortization $3.123B $2.968B $2.679B
YoY Change 16.57% 19.05% 17.81%
% of Gross Profit 32.06% 24.99% 23.72%
Operating Expenses $4.682B $4.976B $4.848B
YoY Change -3.42% -0.54% -3.25%
Operating Profit $5.059B $6.902B $6.447B
YoY Change -21.53% 10.89% -12.27%
Interest Expense $160.0M $618.0M $107.0M
YoY Change 49.53% -225.87% -1.83%
% of Operating Profit 3.16% 8.95% 1.66%
Other Income/Expense, Net -$74.00M $653.0M -$46.00M
YoY Change 60.87% -766.33% -65.15%
Pretax Income $5.041B $8.068B $6.719B
YoY Change -24.97% 43.18% -5.92%
Income Tax $765.0M $1.163B $729.0M
% Of Pretax Income 15.18% 14.41% 10.85%
Net Earnings $4.276B $6.905B $5.990B
YoY Change -28.61% 32.92% -6.38%
Net Earnings / Revenue 23.32% 34.17% 31.21%
Basic Earnings Per Share $1.02 $1.36
Diluted Earnings Per Share $1.02 $1.580M $1.35
COMMON SHARES
Basic Shares Outstanding 4.188B shares 4.391B shares
Diluted Shares Outstanding 4.211B shares 4.433B shares

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.343B $5.276B $5.784B
YoY Change 9.66% -9.14% -4.37%
Cash & Equivalents $3.356B $4.194B $3.935B
Short-Term Investments $2.987B $1.082B $1.849B
Other Short-Term Assets $2.119B $1.713B $2.414B
YoY Change -12.22% -45.83% -31.92%
Inventory $9.273B $8.744B $8.638B
Prepaid Expenses
Receivables $7.140B $7.659B $6.880B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $36.79B $31.24B $29.96B
YoY Change 22.79% 8.52% 1.24%
LONG-TERM ASSETS
Property, Plant & Equipment $59.21B $55.39B $53.56B
YoY Change 10.53% 13.09% 13.79%
Goodwill $26.96B $26.28B $24.73B
YoY Change 9.01% 7.19% 0.9%
Intangibles $9.881B $10.83B $11.02B
YoY Change -10.33% -8.52% -8.23%
Long-Term Investments $9.000M $37.00M $1.180B
YoY Change -99.24% -97.72% -27.78%
Other Assets $6.036B $5.553B $6.255B
YoY Change -3.5% 25.61% 58.15%
Total Long-Term Assets $108.5B $105.3B $103.8B
YoY Change 4.49% 6.16% 5.23%
TOTAL ASSETS
Total Short-Term Assets $36.79B $31.24B $29.96B
Total Long-Term Assets $108.5B $105.3B $103.8B
Total Assets $145.3B $136.5B $133.8B
YoY Change 8.59% 6.69% 4.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.159B $4.128B $4.809B
YoY Change 7.28% 7.95% 33.84%
Accrued Expenses $15.85B $14.19B $14.60B
YoY Change 8.61% 33.25% 25.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $504.0M $3.695B $5.200B
YoY Change -90.31% 385.55% 70.44%
Total Short-Term Liabilities $22.11B $22.31B $25.06B
YoY Change -11.78% 34.19% 28.05%
LONG-TERM LIABILITIES
Long-Term Debt $36.06B $25.31B $23.71B
YoY Change 52.1% 0.84% -4.5%
Other Long-Term Liabilities $3.349B $2.916B $2.506B
YoY Change 33.64% 10.2% -23.2%
Total Long-Term Liabilities $39.41B $28.22B $26.21B
YoY Change 50.34% 1.73% -6.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.11B $22.31B $25.06B
Total Long-Term Liabilities $39.41B $28.22B $26.21B
Total Liabilities $61.52B $50.53B $51.28B
YoY Change 19.98% 13.89% 7.59%
SHAREHOLDERS EQUITY
Retained Earnings $52.16B $53.52B $49.67B
YoY Change 5.0% 6.68% 5.48%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.55B $77.50B $74.24B
YoY Change
Total Liabilities & Shareholders Equity $145.3B $136.5B $133.8B
YoY Change 8.59% 6.69% 4.31%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $4.276B $6.905B $5.990B
YoY Change -28.61% 32.92% -6.38%
Depreciation, Depletion And Amortization $3.123B $2.968B $2.679B
YoY Change 16.57% 19.05% 17.81%
Cash From Operating Activities $8.179B $9.888B $10.71B
YoY Change -23.64% 43.3% 21.23%
INVESTING ACTIVITIES
Capital Expenditures -$3.716B -$4.666B -$4.672B
YoY Change -20.46% 19.95% 21.32%
Acquisitions
YoY Change
Other Investing Activities $2.950B $181.0M $762.0M
YoY Change 287.14% -91.26% 83.17%
Cash From Investing Activities -$766.0M -$4.485B -$3.910B
YoY Change -80.41% 146.43% 13.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $10.00B
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.79B -5.144B -5.733B
YoY Change 123.15% -5.93% 24.44%
NET CHANGE
Cash From Operating Activities 8.179B 9.888B 10.71B
Cash From Investing Activities -766.0M -4.485B -3.910B
Cash From Financing Activities -12.79B -5.144B -5.733B
Net Change In Cash -5.380B 259.0M 1.068B
YoY Change -603.75% -166.75% 34.68%
FREE CASH FLOW
Cash From Operating Activities $8.179B $9.888B $10.71B
Capital Expenditures -$3.716B -$4.666B -$4.672B
Free Cash Flow $11.90B $14.55B $15.38B
YoY Change -22.67% 34.88% 21.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2020-09-26
dei Entity Central Index Key
EntityCentralIndexKey
0000050863
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-26
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80084000000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73321000000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4098000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4290000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4098000000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4290000000 shares
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6447000000 USD
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25494000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23257000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10392000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11547000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15112000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9920000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11220000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12421000000 USD
dei Document Type
DocumentType
10-Q
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3272000000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3208000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9901000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9978000000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1435000000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1536000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4423000000 USD
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-26
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-06217
dei Entity Registrant Name
EntityRegistrantName
INTEL CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-1672743
dei Entity Address Address Line1
EntityAddressAddressLine1
2200 Mission College Boulevard,
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054-1549
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
765-8080
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
dei Trading Symbol
TradingSymbol
INTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4758000000 USD
CY2020Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-25000000 USD
CY2019Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
104000000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
146000000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
288000000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
4682000000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
4848000000 USD
us-gaap Operating Expenses
OperatingExpenses
14470000000 USD
us-gaap Operating Expenses
OperatingExpenses
15024000000 USD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4098000000 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18333000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19190000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57889000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51756000000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8592000000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7895000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25625000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21494000000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
9741000000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
11295000000 USD
us-gaap Gross Profit
GrossProfit
32264000000 USD
us-gaap Gross Profit
GrossProfit
30262000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5059000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6447000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
17794000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
15238000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
56000000 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
318000000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
212000000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
922000000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74000000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-416000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-170000000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5041000000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6719000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17590000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15990000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
765000000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
729000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2548000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1847000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5990000000 USD
us-gaap Net Income Loss
NetIncomeLoss
14143000000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.18
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.14
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4188000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4391000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4233000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4450000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4211000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4433000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4269000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4507000000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5990000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
138000000 USD
us-gaap Net Income Loss
NetIncomeLoss
14143000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
206000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-115000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
257000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-11000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-9000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-34000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-26000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
49000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
88000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
212000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-100000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
340000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
252000000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4488000000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5890000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15382000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14395000000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3356000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4194000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2987000000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1082000000 USD
CY2020Q3 us-gaap Trading Securities
TradingSecurities
11910000000 USD
CY2019Q4 us-gaap Trading Securities
TradingSecurities
7847000000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7140000000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7659000000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
9273000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
8744000000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2119000000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1713000000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
36785000000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
31239000000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59205000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55386000000 USD
CY2020Q3 intc Equity Investments
EquityInvestments
3679000000 USD
CY2019Q4 intc Equity Investments
EquityInvestments
3967000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
2720000000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
3276000000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
26955000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
26276000000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9881000000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10827000000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6036000000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5553000000 USD
CY2020Q3 us-gaap Assets
Assets
145261000000 USD
CY2019Q4 us-gaap Assets
Assets
136524000000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3197000000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3853000000 USD
CY2020Q3 us-gaap Debt Current
DebtCurrent
504000000 USD
CY2019Q4 us-gaap Debt Current
DebtCurrent
3693000000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5159000000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4128000000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13252000000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10636000000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22112000000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22310000000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36059000000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25308000000 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1381000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1368000000 USD
CY2020Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
4811000000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
4919000000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2995000000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2044000000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3349000000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2916000000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
155000000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
23335000000 USD
CY2019Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
25261000000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-940000000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1280000000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
52159000000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53523000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
74554000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
77504000000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145261000000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136524000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4194000000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3019000000 USD
us-gaap Net Income Loss
NetIncomeLoss
14143000000 USD
us-gaap Depreciation
Depreciation
7925000000 USD
us-gaap Depreciation
Depreciation
6647000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1393000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1290000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1311000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1211000000 USD
intc Non Cash Gains Losses On Equity Investments Net
NonCashGainsLossesOnEquityInvestmentsNet
105000000 USD
intc Non Cash Gains Losses On Equity Investments Net
NonCashGainsLossesOnEquityInvestmentsNet
395000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-525000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
156000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
570000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1376000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
355000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
728000000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-488000000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-365000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-91000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-674000000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
493000000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
435000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
296000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1769000000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
10452000000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
9114000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25494000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23257000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3118000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10392000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11547000000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
6323000000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2028000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5037000000 USD
us-gaap Payments To Acquire Trading Securities Heldforinvestment
PaymentsToAcquireTradingSecuritiesHeldforinvestment
14744000000 USD
us-gaap Payments To Acquire Trading Securities Heldforinvestment
PaymentsToAcquireTradingSecuritiesHeldforinvestment
5769000000 USD
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
11227000000 USD
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
5467000000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
339000000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
1414000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
256000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
575000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15112000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9920000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
835000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
10247000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
650000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4525000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1478000000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
897000000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
797000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12229000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10100000000 USD
intc Payments For Accelerated Share Repurchase Forward Agreements
PaymentsForAcceleratedShareRepurchaseForwardAgreements
2000000000 USD
intc Payments For Accelerated Share Repurchase Forward Agreements
PaymentsForAcceleratedShareRepurchaseForwardAgreements
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4215000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4214000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
605000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1089000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11220000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12421000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-838000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
916000000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3356000000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3935000000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2752000000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2376000000 USD
us-gaap Interest Paid Net
InterestPaidNet
459000000 USD
us-gaap Interest Paid Net
InterestPaidNet
312000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1986000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1334000000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
82010000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
4276000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
212000000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
385000000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
452000000 USD
CY2020Q3 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
0 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
74242000000 USD
CY2020Q3 us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
0 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8000000000 USD
CY2020Q3 intc Accelerated Share Repurchases Forward Agreements
AcceleratedShareRepurchasesForwardAgreements
2000000000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
25000000 USD
CY2020Q3 us-gaap Dividends Common Stock
DividendsCommonStock
2756000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
74554000000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
74947000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5990000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-100000000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
466000000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
427000000 USD
CY2019Q3 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
80000000 USD
CY2019Q3 us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
-278000000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4489000000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
28000000 USD
CY2019Q3 us-gaap Dividends Common Stock
DividendsCommonStock
2773000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
77504000000 USD
us-gaap Net Income Loss
NetIncomeLoss
15042000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
340000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
1014000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1393000000 USD
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
155000000 USD
us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
-750000000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
12109000000 USD
intc Accelerated Share Repurchases Forward Agreements
AcceleratedShareRepurchasesForwardAgreements
2000000000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
460000000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
5575000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
74554000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
74563000000 USD
us-gaap Net Income Loss
NetIncomeLoss
14143000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
252000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
869000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1287000000 USD
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
253000000 USD
us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
-990000000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10084000000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
449000000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
5602000000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
74242000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18333000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19190000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57889000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51756000000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5059000000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6447000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
17794000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
15238000000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18333000000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19190000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57889000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51756000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
5990000000 USD
us-gaap Net Income Loss
NetIncomeLoss
14143000000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4188000000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4391000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4233000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4450000000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23000000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
30000000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
16000000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4211000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
36000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
41000000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
12000000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4433000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4269000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4507000000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.18
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.14
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1978000000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2041000000 USD
CY2020Q2 intc Contract With Customer Liability Contract Termination
ContractWithCustomerLiabilityContractTermination
1600000000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
975000000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
840000000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6313000000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6225000000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1985000000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1679000000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
9273000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
8744000000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
53000000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
114000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
229000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
374000000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
160000000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
107000000 USD
us-gaap Interest Expense
InterestExpense
481000000 USD
us-gaap Interest Expense
InterestExpense
381000000 USD
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-84000000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-164000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-163000000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74000000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-416000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-170000000 USD
CY2020Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
81000000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
251000000 USD
CY2019Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
122000000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
366000000 USD
CY2020Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10000000000.0 USD
CY2020Q3 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
166000000 shares
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
7112000000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
124000000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
7236000000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
6481000000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
63000000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6543000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
3504000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1450000000 USD
CY2020Q3 intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
19000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1270000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
1012000000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
7236000000 USD
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
481000000 USD
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
450000000 USD
CY2020Q3 us-gaap Cost Method Investments
CostMethodInvestments
3189000000 USD
CY2019Q4 us-gaap Cost Method Investments
CostMethodInvestments
3480000000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
9000000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
37000000 USD
CY2020Q3 intc Equity Investments
EquityInvestments
3679000000 USD
CY2019Q4 intc Equity Investments
EquityInvestments
3967000000 USD
CY2020Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-146000000 USD
CY2019Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
114000000 USD
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
188000000 USD
CY2020Q3 intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
5000000 USD
CY2019Q3 intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
84000000 USD
intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
142000000 USD
intc Observablepriceadjustmentsonnonmarketable
Observablepriceadjustmentsonnonmarketable
100000000 USD
CY2020Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
40000000 USD
CY2019Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
17000000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
233000000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
79000000 USD
CY2020Q3 intc Other Net Equity Investments
OtherNetEquityInvestments
237000000 USD
CY2019Q3 intc Other Net Equity Investments
OtherNetEquityInvestments
137000000 USD
intc Other Net Equity Investments
OtherNetEquityInvestments
387000000 USD
intc Other Net Equity Investments
OtherNetEquityInvestments
713000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
56000000 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
318000000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
212000000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
922000000 USD
CY2019Q3 intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
281000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-12000000 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-54000000 USD
intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
102000000 USD
intc Equity Securities Fvni Gain Loss Net
EquitySecuritiesFVNIGainLossNet
366000000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-87000000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-321000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
7000000 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
227000000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15000000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
45000000 USD
CY2020Q3 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
150000000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
504000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3700000000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
35185000000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
28751000000 USD
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-374000000 USD
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-529000000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
36563000000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
29003000000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
504000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3695000000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36059000000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25308000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3800000000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
118000000 USD
CY2020Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
45099000000 USD
CY2019Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
40036000000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1996000000 USD
CY2020Q3 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2020Q3 us-gaap Derivative Assets
DerivativeAssets
1996000000 USD
CY2020Q3 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
328000000 USD
CY2020Q3 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
1587000000 USD
CY2020Q3 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
81000000 USD
CY2020Q3 us-gaap Securities Purchased Under Agreements To Resell Gross
SecuritiesPurchasedUnderAgreementsToResellGross
1250000000 USD
CY2020Q3 us-gaap Securities Purchased Under Agreements To Resell Liability
SecuritiesPurchasedUnderAgreementsToResellLiability
0 USD
CY2020Q3 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
1250000000 USD
CY2020Q3 us-gaap Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction
SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction
0 USD
CY2020Q3 us-gaap Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities
SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities
1250000000 USD
CY2020Q3 us-gaap Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2020Q3 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross
3246000000 USD
CY2020Q3 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability
0 USD
CY2020Q3 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed
3246000000 USD
CY2020Q3 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction
328000000 USD
CY2020Q3 intc Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash
2837000000 USD
CY2020Q3 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
81000000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
530000000 USD
CY2020Q3 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
530000000 USD
CY2020Q3 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
328000000 USD
CY2020Q3 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
202000000 USD
CY2020Q3 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
530000000 USD
CY2020Q3 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
530000000 USD
CY2020Q3 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
328000000 USD
CY2020Q3 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
202000000 USD
CY2020Q3 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
974000000 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2019Q4 us-gaap Derivative Assets
DerivativeAssets
974000000 USD
CY2019Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
144000000 USD
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
808000000 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
22000000 USD
CY2019Q4 us-gaap Securities Purchased Under Agreements To Resell Gross
SecuritiesPurchasedUnderAgreementsToResellGross
1850000000 USD
CY2019Q4 us-gaap Securities Purchased Under Agreements To Resell Liability
SecuritiesPurchasedUnderAgreementsToResellLiability
0 USD
CY2019Q4 us-gaap Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
1850000000 USD
CY2019Q4 us-gaap Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction
SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction
0 USD
CY2019Q4 us-gaap Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities
SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities
1850000000 USD
CY2019Q4 us-gaap Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0 USD
CY2019Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross
2824000000 USD
CY2019Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability
0 USD
CY2019Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed
2824000000 USD
CY2019Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction
144000000 USD
CY2019Q4 intc Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash
2658000000 USD
CY2019Q4 us-gaap Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
22000000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
262000000 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
262000000 USD
CY2019Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
144000000 USD
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
72000000 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
46000000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
262000000 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
262000000 USD
CY2019Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
144000000 USD
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
72000000 USD
CY2019Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
46000000 USD
CY2020Q3 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
36000000 USD
CY2019Q3 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-273000000 USD
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-996000000 USD
us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-1312000000 USD
CY2020Q3 intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 USD
CY2019Q3 intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 USD
intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 USD
intc Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge
NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge
0 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="margin-top:15pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:12.151%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:85.649%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#0071c5;text-align:left;vertical-align:bottom;border-bottom:1pt solid #0071c5;padding-left:1pt;padding-right:1pt;"><span style="font-size:14pt;font-weight:700;font-family:'Arial',sans-serif;color:#ffffff;background-color:rgb(255,255,255, 0.0);">NOTE 13 : </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #0071c5;padding-left:1pt;padding-right:1pt;"><span style="font-size:14pt;font-weight:700;font-family:'Arial',sans-serif;color:#0071c5;background-color:rgb(255,255,255, 0.0);">CONTINGENCIES</span></td></tr></table></div><div style="margin-top:9pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0071c5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">LEGAL PROCEEDINGS</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">European Commission Competition Matter</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In 2001, the EC commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ($1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. In November 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice held oral argument in June 2016. In October 2016, Advocate General Wahl, an advisor to the Court of Justice, issued a non-binding advisory opinion that favored Intel on a number of grounds. The Court of Justice issued its decision in September 2017, setting aside the judgment of the General Court and sending the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. The General Court has appointed a panel of five judges to consider our appeal of the EC’s 2009 decision in light of the Court of Justice’s clarifications of the law. In November 2017, the parties filed initial “Observations” about the Court of Justice’s decision and the appeal and were invited by the General Court to offer supplemental comments to each other’s “Observations,” which the parties submitted in March 2018. Responses to other questions posed by the General Court were filed in May and June 2018. The General Court heard oral argument in March 2020. Pending the final decision in this matter, the fine paid by Intel has been placed by the EC in commercial bank accounts where it accrues interest.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Litigation Related to Security Vulnerabilities</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In June 2017, a Google research team notified us and other companies that it had identified security vulnerabilities (now commonly referred to as “Spectre” and “Meltdown”) that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. On January 3, 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Numerous lawsuits have been filed against Intel and, in certain cases, our current and former executives and directors, in U.S. federal and state courts and in certain courts in other countries relating to the Spectre and Meltdown security vulnerabilities, as well as other variants of these vulnerabilities that have since been identified.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">As of October 21, 2020, consumer class action lawsuits relating to the above class of security vulnerabilities publicly disclosed since 2018 were pending in the U.S., Canada, and Israel. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the U.S., numerous individual class action suits filed in various jurisdictions were consolidated in April 2018 for all pretrial proceedings in the U.S. District Court for the District of Oregon. In March 2020, the court granted Intel's motion to dismiss the complaint in that consolidated action but granted plaintiffs leave to amend. Plaintiffs filed an amended complaint in May 2020, which Intel moved to dismiss in July 2020; argument on the motion is scheduled for December 2020. In Canada, in one case pending in the Superior Court of Justice of Ontario, an initial status conference has not yet been scheduled. In a second case pending in the Superior Court of Justice of Quebec, the court has stayed the case until January 2021. In Israel, both consumer class action lawsuits were filed in the District Court of Haifa. In the first case, the District Court denied the parties' joint motion to stay filed in January 2019, but to date has deferred Intel's deadline to respond to the complaint. Intel filed a motion to stay the second case pending resolution of the consolidated proceeding in the U.S., and a hearing on that motion has been scheduled for November 2020. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In addition to these lawsuits, Intel stockholders filed multiple shareholder derivative lawsuits since January 2018 against certain current and former members of our Board of Directors and certain current and former officers, alleging that the defendants breached their duties to Intel in connection with the disclosure of the security vulnerabilities and the failure to take action in relation to alleged insider trading. The complaints sought to recover damages from the defendants on behalf of Intel. Some of the derivative actions were filed in the U.S. District Court for the Northern District of California and were consolidated, and the others were filed in the Superior Court of the State of California in San Mateo County and were consolidated. The federal court granted defendants' motion to dismiss in August 2018 on the ground that plaintiffs failed to plead facts sufficient to show they were excused from making a pre-lawsuit demand on the Board. The federal court granted plaintiffs leave to amend their complaint, but subsequently dismissed the cases in January 2019 at plaintiffs' request. The California Superior Court entered judgment in defendants' favor in August 2020 after granting defendants' motions to dismiss plaintiffs' consolidated complaint and three successive amended complaints, all for failure to plead facts sufficient to show plaintiffs were excused from making pre-lawsuit demand on the Board. Plaintiffs filed a notice of appeal of the California court's judgment in October 2020.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Institute of Microelectronics, Chinese Academy of Sciences v. Intel China, Ltd., et al.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In February 2018, the Institute of Microelectronics of the Chinese Academy of Sciences (IMECAS) sued Intel China, Ltd., Dell China, Ltd. (Dell) and Beijing JingDong Century Information Technology, Ltd. (JD) for patent infringement in the Beijing High Court. IMECAS alleges that Intel’s Core series processors infringe Chinese patent CN 102956457 (’457 Patent). The complaint demands an injunction and damages of at least RMB 200,000,000 plus the cost of litigation. A trial date is not yet set. In March 2018, Dell tendered indemnity to Intel, which Intel granted in April 2018. JD also tendered indemnity to Intel, which Intel granted in October 2018. In March 2018, Intel filed an invalidation request on the ‘457 patent with the Chinese Patent Reexamination Board (PRB). The PRB held an oral hearing in September 2018 and in February 2019 upheld the validity of the challenged claims. In January 2020, Intel filed a second invalidation request on the ‘457 patent with the PRB, for which the PRB heard oral argument in July 2020. In September 2018 and March 2019, Intel filed petitions with the United States Patent &amp; Trademark Office (USPTO) requesting institution of </span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;">inter partes</span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> review (IPR) of U.S. Patent No. 9,070,719, the U.S. counterpart to the ‘457 patent. The USPTO denied institution of Intel’s petitions in March and October 2019, respectively. In April 2019, Intel filed a request for rehearing and a petition for Precedential Opinion Panel (POP) in the USPTO to challenge the denial of its first IPR petition, and in November 2019 Intel filed a request for rehearing on the second IPR petition. In January 2020, the USPTO denied the POP petition on the first IPR petition. In June 2020, the Patent Trial and Appeal Board denied Intel's rehearing requests on both petitions.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In October 2019, IMECAS filed second and third lawsuits, in the Beijing IP Court, alleging infringement of Chinese Patent No. CN 102386226 (‘226 Patent) based on the manufacturing and sale of Intel’s Core i3 microprocessors. Defendants in the second case are Lenovo (Beijing) Co., Ltd. (Lenovo) and Beijing Jiayun Huitong Technology Development Co. Ltd. (BJHT). Defendants in the third case are Intel Corp., Intel China Co., Ltd., the Intel China Beijing Branch, Beijing Digital China Co., Ltd. (Digital China), and JD. Both complaints demand injunctions plus litigation costs and reserve the right to claim damages in unspecified amounts. No proceedings have occurred or are yet scheduled in these lawsuits. In December 2019, Lenovo tendered indemnity to Intel, which Intel granted in March 2020. In July 2020, Intel filed two invalidation requests on the '226 patent with the Chinese PRB. Given the procedural posture and the nature of these cases, the unspecified nature and extent of damages claimed by IMECAS, and uncertainty regarding the availability of injunctive relief under applicable law, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute IMECAS’s claims and intend to vigorously defend against them.</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">VLSI Technology LLC v. Intel</span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In October 2017, VLSI Technology LLC (VLSI) filed a complaint against Intel in the U.S. District Court for the Northern District of California alleging infringement of eight patents acquired from NXP Semiconductors, N.V. (NXP). The patents, which originated at Freescale Semiconductor, Inc. and NXP B.V., are U.S. Patent Nos. 7,268,588; 7,675,806; 7,706,207; 7,709,303; 8,004,922; 8,020,014; 8,268,672; and 8,566,836. VLSI accuses various FPGA and processor products of infringement. VLSI estimated its damages to be as high as $7.1 billion, and its complaint further sought enhanced damages, future royalties, attorneys’ fees, costs, and interest. In May, June, September, and October 2018, Intel filed requests with the Patent Trial and Appeals Board (PTAB) to institute</span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;"> inter partes</span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> review of the patentability of claims in all eight of the patents in-suit. The PTAB instituted review of six patents and denied institution on two patents. As a result of the institution decisions, the parties stipulated to stay the District Court action in March 2019. In December 2019 and February 2020, the PTAB found all claims of the '588 and '303 patents, and some claims of the '922 patent, to be unpatentable. The PTAB found the challenged claims of the '014, '672 and '207 patents to be patentable. Intel moved for a continuation of the stay in March 2020 as it appealed certain rulings by the PTAB. In June 2020, the District Court issued an order continuing the stay through August 2021 and setting trial for December 2022.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In June 2018, VLSI filed a second suit against Intel, in U.S. District Court for the District of Delaware, alleging infringement by various Intel processors of five additional patents acquired from NXP: U.S. Patent Nos. 6,212,663; 7,246,027; 7,247,552; 7,523,331; and 8,081,026. VLSI accused Intel of willful infringement and seeks an injunction or, in the alternative, ongoing royalties, enhanced damages, attorneys’ fees and costs, and interest. In March 2019, the District Court dismissed VLSI’s claims for willful infringement as to all the patents-in-suit except the ‘027 patent, and also dismissed VLSI’s allegations of indirect infringement as to the ‘633, ‘331, and ‘026 patents. In June 2019, Intel filed requests for </span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;">inter partes</span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> review of the patentability of claims in all five patents-in-suit. In January 2020, the District Court vacated the November 2020 trial date based on agreement of the parties; no trial date is currently set. In January and February 2020, the PTAB instituted review of the '552, '633, '331 and '026 patents and as a result Intel moved for stay of the District Court proceedings. In May 2020, the District Court stayed the case as to the '026 and '552 patents but allowed the case to proceed on the '027 and '331 patents. For these two patents, VLSI is seeking damages of approximately $4.13 billion. VLSI also alleges willful infringement and seeks enhanced damages as to the '027 patent. VLSI is no longer asserting claims from the '633 patent. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In March 2019, VLSI filed a third suit against Intel, also in U.S. District Court for the District of Delaware, alleging infringement of six more patents acquired from NXP: U.S. Patent Nos. 6,366,522; 6,663,187; 7,292,485; 7,606,983; 7,725,759; and 7,793,025. In April 2019, VLSI voluntarily dismissed this Delaware case without prejudice. In April 2019, VLSI filed three new infringement suits against Intel in the U.S. District Court for the Western District of Texas (WDTX) accusing various Intel processors of infringement. The three suits collectively assert the same six patents from the voluntarily dismissed Delaware case plus two additional patents acquired from NXP, U.S. Patent Nos. 7,523,373 and 8,156,357. VLSI accuses Intel of willful infringement and seeks an injunction or, in the alternative, ongoing royalties, enhanced damages, attorneys’ fees and costs, and interest. Specifically, VLSI is seeking damages of approximately $11.01 billion collectively in the Texas cases, plus enhanced damages for alleged willful infringement. VLSI seeks approximately $2.5 billion plus enhanced damages for alleged willful infringement in the first Texas case. That case was originally scheduled for trial in November 2020, but the court has now moved trial to January 2021. In October and November 2019, and in February 2020, Intel filed </span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;">inter partes</span><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> review requests on certain asserted claims across six of the patents-in-suit in WDTX. Between May and October 2020, the PTAB denied all of these requests, and Intel is asking for a rehearing on these denials.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts Chinese Patent 201410094015.9 accusing Intel Core processors of infringement. VLSI requests an injunction as well as RMB 1.3 million in damages. Defendants filed an invalidation petition in October 2019. In May 2020, defendants filed a motion to stay the trial court proceedings pending a determination on invalidity. The court has not yet ruled on the motion to stay.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In May 2019, VLSI filed a second case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts Chinese Patent 201080024173.7. The accused Intel products and the claims of VLSI in the Shanghai case are the same as in the Shenzhen case. Defendants filed an invalidation petition in October 2019. In June 2020, defendants filed a motion to stay the trial court proceedings pending a determination on invalidity. The court has not yet ruled on the motion to stay. The court held its first evidentiary hearing in September 2020.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In November 2019, Intel, along with Apple Inc., filed a complaint against Fortress Investment Group LLC, Fortress Credit Co. LLC, Uniloc 2017 LLC, Uniloc USA, Inc., Uniloc Luxembourg S.A.R.L., VLSI, INVT SPE LLC, Inventergy Global, Inc., DSS Technology Management, Inc., IXI IP, LLC, and Seven Networks, LLC. Plaintiffs allege violations of Section 1 of the Sherman Act by certain defendants, Section 7 of the Clayton Act by certain defendants, and California Business and Professions Code section 17200 by all defendants based on defendants' unlawful aggregation of patents. In February 2020, defendants moved to dismiss plaintiffs' complaint. In July 2020, the court granted defendants’ motion to dismiss with leave to amend. The court dismissed antitrust claims related to two DSS patents with prejudice. The plaintiffs filed an amended complaint in August 2020, and defendants moved to dismiss in September 2020. The court will hear defendants' motion to dismiss in December 2020.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In June 2020, affiliates controlled by Fortress Investment Group, which also controls VLSI, acquired Finjan Holdings, Inc. Intel had signed a “Settlement, Release and Patent License Agreement” with Finjan in 2012, acquiring a license to the patents of Finjan and its affiliates, current or future, through a capture period of November 20, 2022. The agreement also contains covenants wherein Finjan agrees to cause its affiliates to comply with the agreement. As such, Intel maintains that it now has a license to the patents of VLSI, which has become a Finjan affiliate, and that Finjan must cause VLSI to dismiss its suits against Intel. In August 2020, Intel started dispute resolution proceedings under the agreement. In September 2020, Intel filed motions to stay the Texas, Delaware, and Shanghai matters pending resolution of its dispute with Finjan. Those motions remain pending.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Given the procedural posture and the nature of these cases and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute VLSI’s claims and intend to vigorously defend against them.</span></div>

Files In Submission

Name View Source Status
0000050863-20-000043-index-headers.html Edgar Link pending
0000050863-20-000043-index.html Edgar Link pending
0000050863-20-000043.txt Edgar Link pending
0000050863-20-000043-xbrl.zip Edgar Link pending
a09262020ex311.htm Edgar Link pending
a09262020ex312.htm Edgar Link pending
a09262020ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
intc-20200926.htm Edgar Link pending
intc-20200926.xsd Edgar Link pending
intc-20200926_cal.xml Edgar Link unprocessable
intc-20200926_def.xml Edgar Link unprocessable
intc-20200926_g1.jpg Edgar Link pending
intc-20200926_g10.jpg Edgar Link pending
intc-20200926_g11.jpg Edgar Link pending
intc-20200926_g12.jpg Edgar Link pending
intc-20200926_g13.jpg Edgar Link pending
intc-20200926_g14.jpg Edgar Link pending
intc-20200926_g15.jpg Edgar Link pending
intc-20200926_g16.jpg Edgar Link pending
intc-20200926_g17.jpg Edgar Link pending
intc-20200926_g18.jpg Edgar Link pending
intc-20200926_g19.jpg Edgar Link pending
intc-20200926_g2.jpg Edgar Link pending
intc-20200926_g20.jpg Edgar Link pending
intc-20200926_g21.jpg Edgar Link pending
intc-20200926_g22.jpg Edgar Link pending
intc-20200926_g23.jpg Edgar Link pending
intc-20200926_g24.jpg Edgar Link pending
intc-20200926_g25.jpg Edgar Link pending
intc-20200926_g26.jpg Edgar Link pending
intc-20200926_g27.jpg Edgar Link pending
intc-20200926_g3.jpg Edgar Link pending
intc-20200926_g4.jpg Edgar Link pending
intc-20200926_g5.jpg Edgar Link pending
intc-20200926_g6.jpg Edgar Link pending
intc-20200926_g7.jpg Edgar Link pending
intc-20200926_g8.jpg Edgar Link pending
intc-20200926_g9.jpg Edgar Link pending
intc-20200926_htm.xml Edgar Link completed
intc-20200926_lab.xml Edgar Link unprocessable
intc-20200926_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending